speb/financial-data huggingface dataset:
LABS.TO cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 5000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Raw Materials: 3279000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 7723000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 8886000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 420000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -120000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Research And Development: 47000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -188630000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Salaries And Wages: 194000.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 35000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 1155000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 4514000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 420755012.00
LABS.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 194000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 37861000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 37141000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
LABS.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 997000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 46597000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 37861000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 423000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 37861000.00
LABS.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 13636000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 8736000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 18667000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
LABS.TO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -2188000.00
LABS.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 19194000.00
LABS.TO income_statement (annual, 2025-12-31) — +Operating Expense: 22376000.00
LABS.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 5873000.00
LABS.TO income_statement (annual, 2025-12-31) — +Total Revenue: 45124000.00
LABS.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 11062000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 4715000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 4715000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 6767000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 6767000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -24337000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -24337000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -20000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -20000.00
LABS.TO cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 179000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 45000.00
LABS.TO cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 179000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 45000.00
LABS.TO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 410000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 183000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 0.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 0.00
LABS.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 418321676.00
LABS.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 424864269.00
LABS.TO income_statement (annual, 2025-12-31) — Basic EPS: -0.02
LABS.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 11690000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 10584000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 25263000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 25263000.00
LABS.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -100000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 51000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 51000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 201904000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 201904000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 10806000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 10806000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 10806000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 10806000.00
LABS.TO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: 0.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
LABS.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -18000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -183000.00
LABS.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 4620000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 0.00
LABS.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -5504000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 435000.00
LABS.TO cash_flow (annual, 2025-12-31) — Change In Inventory: 965000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: 191000.00
LABS.TO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 199000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 288000.00
LABS.TO cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -1776000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 594000.00
LABS.TO cash_flow (annual, 2025-12-31) — Change In Payable: 650000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Change In Payable: 495000.00
LABS.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 650000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 495000.00
LABS.TO cash_flow (annual, 2025-12-31) — Change In Receivables: -63000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: 162000.00
LABS.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -25000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 1730000.00
LABS.TO cash_flow (annual, 2025-12-31) — Changes In Cash: -902000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 252000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Common Stock: 201904000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 201904000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 35812000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 35812000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Construction In Progress: 10000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 10000.00
LABS.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 31156000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 7168000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 2128000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 2128000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Current Assets: 27467000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 27467000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 51000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 51000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Current Debt: 150000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 150000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 201000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 201000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 574000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 574000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 574000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 574000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 9926000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 9926000.00
LABS.TO cash_flow (annual, 2025-12-31) — Depreciation: 1481000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Depreciation: 351000.00
LABS.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1660000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 396000.00
LABS.TO income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 452000.00
LABS.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1660000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 396000.00
LABS.TO income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 452000.00
LABS.TO income_statement (annual, 2025-12-31) — Depreciation Income Statement: 452000.00
LABS.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 418321676.00
LABS.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 424864269.00
LABS.TO income_statement (annual, 2025-12-31) — Diluted EPS: -0.02
LABS.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -8267000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -1968000.00
LABS.TO income_statement (annual, 2025-12-31) — EBIT: -8204000.00
LABS.TO income_statement (quarterly, 2025-12-31) — EBIT: -1949000.00
LABS.TO income_statement (annual, 2025-12-31) — EBITDA: -6544000.00
LABS.TO income_statement (quarterly, 2025-12-31) — EBITDA: -1553000.00
LABS.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 18000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -30000.00
LABS.TO cash_flow (annual, 2025-12-31) — End Cash Position: 10806000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 10806000.00
LABS.TO income_statement (annual, 2025-12-31) — Excise Taxes: 3006000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Excise Taxes: 709000.00
LABS.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -18000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -183000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Finished Goods: 4116000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Finished Goods: 4116000.00
LABS.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: -5604000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 435000.00
LABS.TO cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 147000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
LABS.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 124000.00
LABS.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -37000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 3287000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 3287000.00
LABS.TO income_statement (annual, 2025-12-31) — General And Administrative Expense: 18577000.00
LABS.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 5945000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 675000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 675000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 6787000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 6787000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 41933000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 41933000.00
LABS.TO income_statement (annual, 2025-12-31) — Gross Profit: 13968000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 3894000.00
LABS.TO income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 0.00
LABS.TO income_statement (annual, 2025-12-31) — Insurance And Claims: 248000.00
LABS.TO income_statement (annual, 2025-12-31) — Interest Expense: 63000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 19000.00
LABS.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 63000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 19000.00
LABS.TO income_statement (annual, 2025-12-31) — Interest Income: 232000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Interest Income: 58000.00
LABS.TO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 232000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 58000.00
LABS.TO cash_flow (annual, 2025-12-31) — Interest Paid Cff: -58000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -18000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Inventory: 8018000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 8018000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 35962000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 35962000.00
LABS.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: 4620000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 0.00
LABS.TO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 500000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
LABS.TO balance_sheet (annual, 2025-12-31) — Land And Improvements: 1863000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 1863000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Leases: 209000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Leases: 209000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 0.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 0.00
LABS.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
LABS.TO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 500000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
LABS.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -84000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 385000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 13850000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 13850000.00
LABS.TO cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 26000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 16000.00
LABS.TO income_statement (annual, 2025-12-31) — Net Income: -8267000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Net Income: -1968000.00
LABS.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -8267000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -1968000.00
LABS.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -8267000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -1968000.00
LABS.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -8267000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1968000.00
LABS.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -8267000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1968000.00
LABS.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -8267000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -1968000.00
LABS.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -8267000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -1968000.00
LABS.TO income_statement (annual, 2025-12-31) — Net Interest Income: 169000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: 39000.00
LABS.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -192000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -223000.00
LABS.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 416000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 385000.00
LABS.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 169000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 39000.00
LABS.TO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 232000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 58000.00
LABS.TO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 4685000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
LABS.TO balance_sheet (annual, 2025-12-31) — Net PPE: 17596000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 17596000.00
LABS.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -65000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -100000.00
LABS.TO cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -608000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 35137000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 35137000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 0.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 0.00
LABS.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: -6516000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -1553000.00
LABS.TO income_statement (annual, 2025-12-31) — Normalized Income: -8239000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Normalized Income: -1968000.00
LABS.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: -5504000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 435000.00
LABS.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: -98000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 16000.00
LABS.TO income_statement (annual, 2025-12-31) — Operating Income: -8408000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Operating Income: -1979000.00
LABS.TO income_statement (annual, 2025-12-31) — Operating Revenue: 48130000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 11771000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 424864269.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 424864269.00
LABS.TO balance_sheet (annual, 2025-12-31) — Other Current Assets: 215000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 215000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 150000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 150000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 3287000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 3287000.00
LABS.TO income_statement (annual, 2025-12-31) — Other Gand A: 8187000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Other Gand A: -3312000.00
LABS.TO income_statement (annual, 2025-12-31) — Other Income Expense: -28000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 675000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 675000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Other Inventories: 168000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Other Inventories: 168000.00
LABS.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: -574000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -166000.00
LABS.TO income_statement (annual, 2025-12-31) — Other Operating Expenses: 170000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 243000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Other Payable: 706000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Other Payable: 706000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Other Properties: 738000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 738000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Other Receivables: 423000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 423000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Payables: 5421000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Payables: 5421000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 7549000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 7549000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1602000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1602000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Prepaid Assets: 899000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 899000.00
LABS.TO income_statement (annual, 2025-12-31) — Pretax Income: -8267000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Pretax Income: -1968000.00
LABS.TO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
LABS.TO balance_sheet (annual, 2025-12-31) — Properties: 0.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
LABS.TO income_statement (annual, 2025-12-31) — Provision For Doubtful Accounts: 46000.00
LABS.TO cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 46000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 33000.00
LABS.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -100000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Raw Materials: 3734000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Raw Materials: 3734000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Receivables: 7529000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 7529000.00
LABS.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 29948000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 7168000.00
LABS.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1660000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 396000.00
LABS.TO income_statement (annual, 2025-12-31) — Rent And Landing Fees: 406000.00
LABS.TO income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 406000.00
LABS.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -692000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -223000.00
LABS.TO income_statement (annual, 2025-12-31) — Research And Development: 223000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Research And Development: 52000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: -169379000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -169379000.00
LABS.TO income_statement (annual, 2025-12-31) — Salaries And Wages: 9736000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Salaries And Wages: 8603000.00
LABS.TO cash_flow (annual, 2025-12-31) — Sale Of PPE: 35000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 0.00
LABS.TO income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 2908000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: -865000.00
LABS.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 21485000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 5080000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Share Issued: 424864269.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 424864269.00
LABS.TO cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -608000.00
LABS.TO income_statement (annual, 2025-12-31) — Special Income Charges: 9000.00
LABS.TO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1344000.00
LABS.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 211000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 35812000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 35812000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 35137000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 35137000.00
LABS.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
LABS.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
LABS.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
LABS.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
LABS.TO balance_sheet (annual, 2025-12-31) — Taxes Receivable: 339000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 339000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Total Assets: 45738000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 45738000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 35812000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 35812000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Total Debt: 201000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 201000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 35812000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 35812000.00
LABS.TO income_statement (annual, 2025-12-31) — Total Expenses: 53532000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 13041000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 9926000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 9926000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 18271000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 18271000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
LABS.TO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -8436000.00
LABS.TO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -2007000.00
LABS.TO income_statement (annual, 2025-12-31) — Total Unusual Items: -28000.00
LABS.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -28000.00
LABS.TO balance_sheet (annual, 2025-12-31) — Working Capital: 17541000.00
LABS.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 17541000.00
LABS.TO income_statement (annual, 2025-12-31) — Write Off: 115000.00
LABS.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 4234000.00
LABS.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 8963000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 4565000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 5774000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -24675000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -22000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 22000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 424864269.00
LABS.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 0.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 10806000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 25263000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -1000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -1000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 18000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 201904000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 9866000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 9866000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: 0.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -138000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -1000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -824000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Change In Inventory: -623000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 257000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 295000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Change In Payable: -1517000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -1517000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: 993000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -595000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 993000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -963000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 201904000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 35097000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 11000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 5641000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 1560000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 25728000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 18000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 18000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 352000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 352000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 8521000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 382000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 382000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 424864269.00
LABS.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.00
LABS.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -867000.00
LABS.TO income_statement (quarterly, 2026-03-31) — EBIT: -852000.00
LABS.TO income_statement (quarterly, 2026-03-31) — EBITDA: -470000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 23000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 9866000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Excise Taxes: 643000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -138000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Finished Goods: 4105000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -825000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 3439000.00
LABS.TO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 2996000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 630000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 5796000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 41934000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 3322000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 15000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 15000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Interest Income: 60000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 60000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Interest Paid Cff: -14000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 8471000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 35097000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -1000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 1863000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Leases: 209000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -184000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 13850000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -25000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Net Income: -867000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -867000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -867000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -867000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -867000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -867000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -867000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: 45000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -184000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -184000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 45000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 60000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 17259000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 34467000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -470000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Normalized Income: -867000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -824000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -25000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Operating Income: -912000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 9606000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 424864269.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 240000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 3439000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Other Gand A: 2842000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 630000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Other Inventories: 93000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 103000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Other Operating Expenses: -84000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Other Payable: 714000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Other Properties: 738000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Other Receivables: 71000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Payables: 5279000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 6839000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1312000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 617000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Pretax Income: -867000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 2000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Raw Materials: 4273000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 6534000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 5641000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 382000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Rent Expense Supplemental: 342000.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -184000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Research And Development: 24000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -170246000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Salaries And Wages: 154000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 1298000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 4294000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 424864269.00
LABS.TO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 154000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 35097000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 34467000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
LABS.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 689000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 43618000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 35097000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 18000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 35097000.00
LABS.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 9875000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 8521000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 17890000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
LABS.TO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -912000.00
LABS.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: 17207000.00
LABT income_statement (annual, 2023-12-31) — +Operating Expense: 8636719.00
LABT income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
LABT balance_sheet (annual, 2023-12-31) — Accounts Payable: 499066.00
LABT balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -57245.00
LABT balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 49302689.00
LABT cash_flow (annual, 2023-12-31) — Amortization Of Securities: -76524.00
LABT income_statement (annual, 2023-12-31) — Basic Average Shares: 699546.00
LABT income_statement (annual, 2023-12-31) — Basic EPS: -11.84
LABT cash_flow (annual, 2023-12-31) — Beginning Cash Position: 13130057.00
LABT balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 378884.00
LABT balance_sheet (annual, 2023-12-31) — Capital Stock: 3726.00
LABT balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 2529756.00
LABT balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 6390467.00
LABT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 0.00
LABT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -3784187.00
LABT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -6816114.00
LABT cash_flow (annual, 2023-12-31) — Change In Account Payable: 54371.00
LABT cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 853309.00
LABT cash_flow (annual, 2023-12-31) — Change In Interest Payable: 9007.00
LABT cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -400.00
LABT cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -99801.00
LABT cash_flow (annual, 2023-12-31) — Change In Payable: 54371.00
LABT cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 907680.00
LABT cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 5667.00
LABT cash_flow (annual, 2023-12-31) — Change In Working Capital: 813146.00
LABT cash_flow (annual, 2023-12-31) — Changes In Cash: -10600301.00
LABT balance_sheet (annual, 2023-12-31) — Common Stock: 686.00
LABT balance_sheet (annual, 2023-12-31) — Common Stock Equity: 4555287.00
LABT cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
LABT balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 1257627.00
LABT balance_sheet (annual, 2023-12-31) — Current Assets: 6480556.00
LABT balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 106022.00
LABT balance_sheet (annual, 2023-12-31) — Current Debt: 200000.00
LABT balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 306022.00
LABT balance_sheet (annual, 2023-12-31) — Current Liabilities: 2062715.00
LABT balance_sheet (annual, 2023-12-31) — Current Notes Payable: 200000.00
LABT cash_flow (annual, 2023-12-31) — Depreciation: 120985.00
LABT cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 120985.00
LABT income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 11563.00
LABT cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 120985.00
LABT income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 11563.00
LABT income_statement (annual, 2023-12-31) — Depreciation Income Statement: 11563.00
LABT income_statement (annual, 2023-12-31) — Diluted Average Shares: 699546.00
LABT income_statement (annual, 2023-12-31) — Diluted EPS: -11.84
LABT income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -8281960.00
LABT income_statement (annual, 2023-12-31) — EBIT: -8271960.00
LABT income_statement (annual, 2023-12-31) — EBITDA: -8150975.00
LABT cash_flow (annual, 2023-12-31) — End Cash Position: 2529756.00
LABT cash_flow (annual, 2023-12-31) — Financing Cash Flow: 0.00
LABT cash_flow (annual, 2023-12-31) — Free Cash Flow: -6816114.00
LABT income_statement (annual, 2023-12-31) — General And Administrative Expense: 3096208.00
LABT balance_sheet (annual, 2023-12-31) — Gross PPE: 462046.00
LABT income_statement (annual, 2023-12-31) — Insurance And Claims: 78671.00
LABT income_statement (annual, 2023-12-31) — Interest Expense: 10000.00
LABT income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 10000.00
LABT income_statement (annual, 2023-12-31) — Interest Income: 360122.00
LABT income_statement (annual, 2023-12-31) — Interest Income Non Operating: 360122.00
LABT cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 993.00
LABT balance_sheet (annual, 2023-12-31) — Interest Payable: 138020.00
LABT balance_sheet (annual, 2023-12-31) — Invested Capital: 4755287.00
LABT cash_flow (annual, 2023-12-31) — Investing Cash Flow: -3784187.00
LABT balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 272862.00
LABT balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 272862.00
LABT balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 70021.00
LABT cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
LABT income_statement (annual, 2023-12-31) — Net Income: -8281960.00
LABT income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -8281960.00
LABT income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -8281960.00
LABT income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -8281960.00
LABT income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -8281960.00
LABT cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -8281960.00
LABT income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -8281960.00
LABT income_statement (annual, 2023-12-31) — Net Interest Income: 350122.00
LABT cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -3784187.00
LABT income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 350122.00
LABT balance_sheet (annual, 2023-12-31) — Net PPE: 404801.00
LABT cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 0.00
LABT balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 4558327.00
LABT income_statement (annual, 2023-12-31) — Normalized EBITDA: -8150975.00
LABT income_statement (annual, 2023-12-31) — Normalized Income: -8281960.00
LABT cash_flow (annual, 2023-12-31) — Operating Cash Flow: -6816114.00
LABT income_statement (annual, 2023-12-31) — Operating Income: -8636719.00
LABT income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
LABT balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 1393564.00
LABT balance_sheet (annual, 2023-12-31) — Other Current Assets: 90089.00
LABT income_statement (annual, 2023-12-31) — Other Gand A: 1166453.00
LABT income_statement (annual, 2023-12-31) — Other Income Expense: 4637.00
LABT balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 8547.00
LABT income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 4637.00
LABT balance_sheet (annual, 2023-12-31) — Other Properties: 392025.00
LABT balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 3860711.00
LABT balance_sheet (annual, 2023-12-31) — Payables: 499066.00
LABT balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 1756693.00
LABT balance_sheet (annual, 2023-12-31) — Preferred Stock: 3040.00
LABT balance_sheet (annual, 2023-12-31) — Preferred Stock Equity: 3040.00
LABT income_statement (annual, 2023-12-31) — Pretax Income: -8281960.00
LABT cash_flow (annual, 2023-12-31) — Purchase Of Investment: -11129187.00
LABT cash_flow (annual, 2023-12-31) — Purchase Of PPE: 0.00
LABT income_statement (annual, 2023-12-31) — Reconciled Depreciation: 120985.00
LABT cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
LABT income_statement (annual, 2023-12-31) — Research And Development: 5528948.00
LABT balance_sheet (annual, 2023-12-31) — Retained Earnings: -44648088.00
LABT income_statement (annual, 2023-12-31) — Salaries And Wages: 1851084.00
LABT cash_flow (annual, 2023-12-31) — Sale Of Investment: 7345000.00
LABT income_statement (annual, 2023-12-31) — Selling General And Administration: 3096208.00
LABT balance_sheet (annual, 2023-12-31) — Share Issued: 1393564.00
LABT income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
LABT cash_flow (annual, 2023-12-31) — Stock Based Compensation: 608239.00
LABT balance_sheet (annual, 2023-12-31) — Stockholders Equity: 4558327.00
LABT balance_sheet (annual, 2023-12-31) — Tangible Book Value: 4555287.00
LABT income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
LABT income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
LABT balance_sheet (annual, 2023-12-31) — Total Assets: 6893904.00